2021

1. DAPA-RWE: A retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain

   Journal of Comparative Effectiveness Research, Vol. 10, Núm. 10, pp. 815-821